138 related articles for article (PubMed ID: 31899233)
1. Risk Factors for Infection after Prostate Biopsy in the United States.
Shoag JE; Gaffney C; Pantuck M; Sun T; Gorin M; Schaeffer E; Sedrakyan A; Vickers A; Hu J
Urology; 2020 Apr; 138():113-118. PubMed ID: 31899233
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
[TBL] [Abstract][Full Text] [Related]
3. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
[TBL] [Abstract][Full Text] [Related]
4. Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997.
Roberts RO; Bergstralh EJ; Besse JA; Lieber MM; Jacobsen SJ
Urology; 2002 Jan; 59(1):79-84. PubMed ID: 11796286
[TBL] [Abstract][Full Text] [Related]
5. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
Eggener S
Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
[TBL] [Abstract][Full Text] [Related]
6. Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Chiu PK; Alberts AR; Venderbos LDF; Bangma CH; Roobol MJ
BJU Int; 2017 Sep; 120(3):394-400. PubMed ID: 28498624
[TBL] [Abstract][Full Text] [Related]
7. Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection?
Billingsley KG; Morris AM; Green P; Dominitz JA; Matthews B; Dobie SA; Barlow W; Baldwin LM
J Am Coll Surg; 2008 Jun; 206(6):1167-77. PubMed ID: 18501815
[TBL] [Abstract][Full Text] [Related]
8. Complications after prostate biopsy: data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2011 Nov; 186(5):1830-4. PubMed ID: 21944136
[TBL] [Abstract][Full Text] [Related]
9. Implications of intensive care unit admissions among medicare beneficiaries following resection of pancreatic cancer.
Rice DR; Hyer JM; Tsilimigras D; Pawlik TM
J Surg Oncol; 2022 Mar; 125(3):405-413. PubMed ID: 34608989
[TBL] [Abstract][Full Text] [Related]
10. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
11. Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.
Lahdensuo K; Rannikko A; Anttila VJ; Erickson A; Pätäri-Sampo A; Rautio M; Santti H; Tarkka E; Vaara M; Huotari K
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):417-422. PubMed ID: 27526964
[TBL] [Abstract][Full Text] [Related]
12. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States.
Hyder O; Dodson RM; Nathan H; Schneider EB; Weiss MJ; Cameron JL; Choti MA; Makary MA; Hirose K; Wolfgang CL; Herman JM; Pawlik TM
JAMA Surg; 2013 Dec; 148(12):1095-102. PubMed ID: 24108580
[TBL] [Abstract][Full Text] [Related]
13. Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.
Roberts MJ; Bennett HY; Harris PN; Holmes M; Grummet J; Naber K; Wagenlehner FME
Urology; 2017 Jun; 104():11-21. PubMed ID: 28007492
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
Liauw SL; Ham SA; Das LC; Rudra S; Packiam VT; Koshy M; Weichselbaum RR; Becker YT; Bodzin AS; Eggener SE
J Natl Cancer Inst; 2020 Aug; 112(8):847-854. PubMed ID: 31728517
[TBL] [Abstract][Full Text] [Related]
15. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
[TBL] [Abstract][Full Text] [Related]
16. Aggressiveness of intensive care use among patients with lung cancer in the Surveillance, Epidemiology, and End Results-Medicare registry.
Cooke CR; Feemster LC; Wiener RS; O'Neil ME; Slatore CG
Chest; 2014 Oct; 146(4):916-923. PubMed ID: 25117058
[TBL] [Abstract][Full Text] [Related]
17. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
[TBL] [Abstract][Full Text] [Related]
18. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
20. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
Cheung C; Patel HD; Landis P; Carter HB; Han M
Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
